摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

{6-[2-tert-butyl-5-(2,4-difluorophenyl)-3H-imidazol-4-yl]-3-nitropyridin-2-yl}-(2,2-dimethylpropyl)amine | 862507-56-0

中文名称
——
中文别名
——
英文名称
{6-[2-tert-butyl-5-(2,4-difluorophenyl)-3H-imidazol-4-yl]-3-nitropyridin-2-yl}-(2,2-dimethylpropyl)amine
英文别名
6-[2-tert-butyl-4-(2,4-difluorophenyl)-1H-imidazol-5-yl]-N-(2,2-dimethylpropyl)-3-nitropyridin-2-amine
{6-[2-tert-butyl-5-(2,4-difluorophenyl)-3H-imidazol-4-yl]-3-nitropyridin-2-yl}-(2,2-dimethylpropyl)amine化学式
CAS
862507-56-0
化学式
C23H27F2N5O2
mdl
——
分子量
443.496
InChiKey
VGAAVMGXZXJCHD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.7
  • 重原子数:
    32
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    99.4
  • 氢给体数:
    2
  • 氢受体数:
    7

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38α MAP kinase inhibitors with excellent in vivo antiinflammatory properties
    摘要:
    Herein we report investigations into the p38 alpha MAP kinase activity of trisubstituted imidazoles that led to the identification of compounds possessing highly potent in vivo activity. The SAR of a novel series of imidazopyridines is demonstrated as well, resulting in compounds possessing cellular potency and enhanced in vivo activity in the rat collagen-induced arthritis model of chronic inflammation. (C) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.10.106
  • 作为产物:
    参考文献:
    名称:
    Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38α MAP kinase inhibitors with excellent in vivo antiinflammatory properties
    摘要:
    Herein we report investigations into the p38 alpha MAP kinase activity of trisubstituted imidazoles that led to the identification of compounds possessing highly potent in vivo activity. The SAR of a novel series of imidazopyridines is demonstrated as well, resulting in compounds possessing cellular potency and enhanced in vivo activity in the rat collagen-induced arthritis model of chronic inflammation. (C) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.10.106
点击查看最新优质反应信息

文献信息

  • KINASE INHIBITORS
    申请人:ELI LILLY AND COMPANY
    公开号:EP1713805B1
    公开(公告)日:2009-06-10
查看更多